Imagen de Portada

Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Virginia Solitano, Guangyong Zou, Vipul Jairath
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alimentary Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Letter: Bowel Preparation Quality in Patients With Crohn's Disease
por: Tamar Schildkraut, et al.
Publicado: (2024)

Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply
por: Jeffrey D McCurdy, et al.
Publicado: (2025)

Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' Reply
por: Jeffrey D. McCurdy, et al.
Publicado: (2025)

Letter: Incremental Value and Outcome Modelling in Frailty Assessment for Older Patients with Inflammatory Bowel Disease. Author's Reply
por: A. B. Fons, et al.
Publicado: (2026)

Performance of bowel preparation quality scales in patients with Crohn's disease
por: Virginia Solitano, et al.
Publicado: (2024)

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply
por: Isabel Carbery, et al.
Publicado: (2024)

Letter: Allostatic Load and Adverse Prognosis in Inflammatory Bowel Disease—Need More Evidence. Authors' Reply
por: Jianhui Zhao, et al.
Publicado: (2024)

Meta‐Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease
por: Purab Patel, et al.
Publicado: (2025)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story? Authors' Reply
por: Sanjay K. Murthy
Publicado: (2026)

Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply
por: Jianhui Zhao, et al.
Publicado: (2024)

Letter: Early Ileal Resection in Crohn's Disease Is Not Associated With Severe Long‐Term Outcomes: The ERIC Study: Authors' Reply
por: Nathan Grellier, et al.
Publicado: (2025)

Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound
por: Sara Massironi, et al.
Publicado: (2025)

Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases
por: Dhruv Ahuja, et al.
Publicado: (2025)

Editorial: Can We Prevent Inflammatory Bowel Disease? Authors' Reply
por: Fai Fai Ho, et al.
Publicado: (2025)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease: Authors' Reply
por: Suprabhat Giri, et al.
Publicado: (2025)

Editorial: Are Antidepressant Medications Safe in Inflammatory Bowel Disease? Authors' Reply
por: Bharati Kochar, et al.
Publicado: (2025)

Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply
por: José Luis Rueda García, et al.
Publicado: (2026)

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply
por: Péter Bacsur, et al.
Publicado: (2024)

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply
por: Anupam Kumar Singh, et al.
Publicado: (2026)

Editorial: Optimal Treatment for Older Patients With Inflammatory Bowel Disease: How to Detect and Manage Frailty? Authors' Reply
por: A. B. Fons, et al.
Publicado: (2026)

Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
por: José Luis Rueda García, et al.
Publicado: (2026)

Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues. Authors' Reply
por: Jessica A. Fitzpatrick, et al.
Publicado: (2025)

Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease. Authors' Reply
por: Cristina Rubín de Célix, et al.
Publicado: (2025)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet? Author's Reply
por: Aurelien Amiot, et al.
Publicado: (2025)

Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease? Authors' Reply
por: Nicolas Richard, et al.
Publicado: (2025)

The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review
por: Olga M. Nardone, et al.
Publicado: (2025)

Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply
por: Nina Dominik, et al.
Publicado: (2024)

Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease—Authors' Reply
por: Jessica D. Lee, et al.
Publicado: (2025)

Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply
por: Lichao Qiao, et al.
Publicado: (2025)

Editorial: JAK to JAK—Navigating Intra‐Class JAK Inhibitor Switching in Inflammatory Bowel Disease. Authors' Reply
por: Mathieu Uzzan, et al.
Publicado: (2025)

Letter: Drug‐Induced Autoimmune‐Like Hepatitis—A Trigger on the Disease Spectrum. Authors' Reply
por: Pinelopi Arvaniti, et al.
Publicado: (2025)

Letter: Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV—Authors' Reply
por: Juan Macias, et al.
Publicado: (2025)

Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
por: Runqi Wang, et al.
Publicado: (2026)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
por: Lukas Burghart, et al.
Publicado: (2026)

Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease—Author's Reply
por: Eunice Yewon Lee, et al.
Publicado: (2024)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease. Authors' Reply
por: Walter W. Chan, et al.
Publicado: (2026)

Letter: Thiopurines the Silent Workhorse for Many Patients After a Flare of Ulcerative Colitis. Authors' Reply
por: Ankit Kumar, et al.
Publicado: (2026)

Letter on: ‘Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS ’. Authors' Reply
por: Christian Labenz, et al.
Publicado: (2026)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply
por: Ryan M. Mathias, et al.
Publicado: (2025)

Letter: Toward Intra‐Class Switching With JAK Inhibitors? Authors' Reply
por: Shintaro Akiyama, et al.
Publicado: (2025)